VVUS "reports weak sales of Qysmia" and stock is up 60+ cents! http://www.reuters.com/article/2013/05/08/vivus-results-idUSL3N0DP2W420130508?feedType=RSS&feedName=rbssHealthcareNews&rpc=43 Looks like ARNA will have to generate some serious sales numbers to hurt the shorts.IMO